GLP-1 medications are transforming the treatment of obesity, a challenge affecting millions of U.S. workers. Yet the high cost is a significant concern for companies looking to balance access with affordability. In this session, leaders from Noom will break down the GLP-1 cost cycle and identify ways organizations can provide affordable access to GLP-1s and other anti-obesity medications regardless of their coverage policies. You'll learn how the obesity crisis is affecting employers, the impact of GLP-1 compounds, and how Noom can help you confidently manage GLP-1 costs and achieve long-term return on investment.

From Day One is a Recertification Provider for SHRM and HRCI. This session is eligible for 1 PDC. The Activity ID will be sent to attendees after the conclusion of the session.

This session is hosted by the From Day One editorial team with support from Noom Health.